GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Labopharm Inc. (DDSSF) [hlAlert]

Rating:
Sector Underperform
DDSS
up 342.99 %

Labopharm Inc. (DDSS) rated Sector Underperform by CIBC Wrld Mkts

Posted on: Monday,  Aug 11, 2008  8:25 AM ET by CIBC Wrld Mkts

CIBC Wrld Mkts rated Sector Underperform Labopharm Inc. (NASDAQ: DDSSF) on 08/11/2008, when the stock price was $1.22.
Since then, Labopharm Inc. has lost 77.43% as of 10/12/2011's recent price of $0.28.
If you would have followed this CIBC Wrld Mkts's recommendation on DDSSF, you would have gained 342.99% of your investment in 1157 days.

Labopharm Inc. is an international specialty pharmaceutical company focused on improving existing drugs by incorporating its advanced controlled-release technologies. The Company develops products internally in order to enter into strategic alliances or licensing agreements with national or international pharmaceutical companies that have the necessary resources and distribution networks to market and sell its pharmaceutical products. The Company?s wholly owned subsidiaries include Labopharm Europe Limited, Labopharm (Barbados) Limited, Labopharm Cyprus Limited and Labopharm USA, Inc. The global commercialization program for its lead product, a once-daily formulation of the analgesic tramadol, is underway and it has multiple follow-on products in the later stages of development. Its once-daily tramadol product has been launched in 15 countries.

CIBC World Markets strives to deliver leading edge investment research to investing clients through our multi-faceted, firm-wide research product offering. Our research has consistently been recognized as a top research source for its breadth of coverage, industry knowledge and quality of work in generating profitable and timely investment ideas. We provide in-depth coverage for all of the major sectors of the Canadian economy and select coverage of U.S. companies. Our analytical teams remain committed to identifying trends early and developing exploitable investment opportunities across the market capitalization spectrum. With the continued growth in quantitative and computerized investing strategies, we have also developed leading edge quantitative and technical research products to partner with our fundamental approach. Our products are available through several automated avenues: email, website, and third-party market vendors. Client service is our driving force and we constantly advance in offering greater product customization options.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
8/11/2008 8:25 AM Sell
None
1.22
as of 1/1/0001
1 Week   
1 Month   
3 Months   
1 YTD   

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy